| 摘要 |
Present invention relates to effervescent formulations comprising cefixime and clavulanic acid and/or pharmaceutically acceptable salts, hydrates, enantiomers, racemates, organic salts, inorganic salts, esters, polymorphs, crystal forms and amorphous forms and/or combinations thereof suitable for oral use in treatment of infectious diseases caused by resistant bacteria. Furthermore, since these active agents are given to the patients freshly right after dispersing in water, they have higher shelf life with respect to the suspension forms and they have higher bioavailability. Use of effervescent formulations is much easier for especially geriatric and pediatric patients which experience swallowing difficulties with respect to the capsule and tablet forms. |
